Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Minerva Neuroscie (NQ: NERV )

0.3600 UNCHANGED
Streaming Delayed Price Updated: 3:58 PM EDT, May 23, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.3600
Bid (Size) 0.3823 (1)
Ask (Size) 0.4020 (10)
Prev. Close 0.3600
Today's Range 0.3600 - 0.3600
52wk Range 0.3305 - 3.140
Shares Outstanding 42,721,566
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: Minerva Neurosciences Q1 Earnings
Minerva Neurosciences (NASDAQ:NERV) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-60.87%
-60.87%
1 Month
-44.04%
-44.04%
3 Month
-48.57%
-48.57%
6 Month
-67.86%
-67.86%
1 Year
-88.12%
-88.12%

More News

Read More
Minerva Outlines Next Steps For US Application For Schizophrenia Candidate
Via Benzinga
20 Stocks Moving Toward VWAP Breakout: GameStop, Roku, Moderna And More
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Minerva Neurosciences: Q4 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
26 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
15 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 8, 2021
Via Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Via Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Via Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Via Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
Via Benzinga
22 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
3 Downgraded Stocks to Sell in a Shaky Market
Via Talk Markets
Exposures COVID-19
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Via Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.